See comprehensive RWI table for a complete list of companies pertaining to this organization. None All sections Appendix 1. Continued Committee Member Employment Consultant Speakers Bureau Ownership/ Partnership/ Principal Personal Research Institutional, Organizational, or Other Financial Benefit Expert Witness Voting Recusals by Section* (Continued) Marc S. Sabatine Brigham and Women s Hospital, Chairman TIMI Study Group, Division of Cardiovascular Medicine; Harvard Medical School Professor of Medicine Amgen AstraZeneca Bristol-Myers Squibb Merck Pfizer Sanofi-aventis None None Abbott Laboratories Amgen AstraZeneca Bristol-Myers Squibb Critical Diagnostics Daiichi-Sankyo Genzyme GlaxoSmithKline Nanosphere Roche Diagnostics Sanofi-aventis Takeda AstraZeneca Daiichi-Sankyo Gilead Johnson & Johnson BRAHMS Proventys Siemens Singulex None All sections except and 8. Richard W. Smalling University of Texas, Health Science Center at Houston Professor and Director of Interventional Cardiovascular Medicine; James D. Woods Distinguished Chair in Cardiovascular Medicine Gilead Maquet None None Cordis E-valve Abbott Vascular Edwards Lifesciences Gilead Maquet Datascope Cordis E-valve None All sections except 7.8, and 8. Susan J. Zieman National Institute on Aging/NIH, Geriatrics Branch, Division of Geriatrics and Clinical Gerontology Medical Officer None None None None None None None This table represents the relationships of committee members with industry and other entities that were determined to be relevant to this document. These relationships were reviewed and updated in conjunction with all meetings and/or conference calls of the GWC during the document development process. The table does not necessarily reflect relationships with industry at the time of publication. 